Compugen (CGEN) Cash from Investing Activities (2009 - 2010)

Compugen (CGEN) reported Cash from Investing Activities of $3.0 million for Q4 2010, up 651.12% on a YoY basis from $394746.3 in Q4 2009, and up 140.55% sequentially from -$7.3 million in Q3 2010.

Compugen (CGEN) Cash from Investing Activities (2009 - 2010) Analysis & Trends

Compugen (CGEN) has 2 years of Cash from Investing Activities data on file, last reported at $3.0 million in Q4 2010.

  • For the quarter ending Q4 2010, Cash from Investing Activities rose 651.12% year-over-year to $3.0 million; the trailing twelve-month figure through Dec 2010 stood at -$4.9 million (changed N/A YoY), and the FY2025 full-year result was $30.0 million, up 164.85% from the prior year.
  • Cash from Investing Activities rose to $3.0 million in Q4 2010, from -$7.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $3.0 million in Q4 2010 to a low of -$7.3 million in Q3 2010.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 172.62 Mn
10 Compugen 215.59 Mn 123.84 Mn 352,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2010 2.97 Mn
Dec 31, 2010 2.97 Mn
Sep 30, 2010 -7.31 Mn
Sep 30, 2010 -7.31 Mn
Dec 31, 2009 -538,000.00
Dec 31, 2009 -538,000.00
Sep 30, 2009 18,000.00
Sep 30, 2009 18,000.00